Safety and Efficacy of Low Dosage of Urokinase for Catheter-directed Thrombolysis of Deep Venous Thrombosis.
- Author:
Xiao-Long DU
;
Ling-Shang KONG
;
Qing-You MENG
;
Aimin QIAN
;
Wen-Dong LI
;
Hong CHEN
;
Xiao-Qiang LI
1
;
Cheng-Long LI
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urokinase-Type Plasminogen Activator; administration & dosage; adverse effects; therapeutic use; Venous Thrombosis; drug therapy; Young Adult
- From: Chinese Medical Journal 2015;128(13):1787-1792
- CountryChina
- Language:English
-
Abstract:
BACKGROUNDCatheter-directed thrombolysis (CDT) has been a mainstay in treating deep venous thrombosis (DVT). However, the optimal dosage of a thrombolytic agent is still controversial. The goal of this study was to evaluate the safety and efficacy of low dosage urokinase with CDT for DVT.
METHODSA retrospective analysis was performed using data from a total of 427 patients with DVT treated with CDT in our single center between July 2009 and December 2012. Early efficacy of thrombolysis was assessed with a thrombus score based on daily venography. The therapeutic safety was evaluated by adverse events. A venography or duplex ultrasound was performed to assess the outcome at 6 months, 1 year and 2 years postoperatively.
RESULTSThe mean total dose of 3.34 (standard deviation [SD] 1.38) million units of urokinase was administered during a mean of 5.18 (SD 2.28) days. Prior to discharge, Grade III (complete lysis) was achieved in 154 (36%) patients; Grade II (50-99% lysis) in 222 (52%); and Grade I (50% lysis) in 51 (12%). The major complications included one intracranial hemorrhage, one hematochezia, five gross hematuria, and one pulmonary embolism. Moreover, no death occurred in the study.
CONCLUSIONSTreatment of low-dose catheter-directed thrombosis is an efficacious and safe therapeutic approach in patients with DVT offering good long-term outcomes and minimal complications.